Logo image
Impact of Local Tumor Relapse on Patient Survival after Cobalt 60 Plaque Radiotherapy
Journal article   Peer reviewed

Impact of Local Tumor Relapse on Patient Survival after Cobalt 60 Plaque Radiotherapy

Tamara R. Vrabec, James J. Augsburger, John W. Gamel, Luther W. Brady, Carlos Hernandez and Reginald Woodleigh
Ophthalmology (Rochester, Minn.), v 98(6), pp 984-988
Jun 1991
PMID: 1866154

Abstract

The authors investigated the impact of local intraocular tumor relapse on survival in a matched-group comparison study of patients with primary choroidal or ciliary body melanoma managed with cobalt 60 plaque radiotherapy. Sixty-two patients with local relapse were matched with an equal number of relapse-free patients in terms of known clinical prognostic factors for both melanoma-specific mortality (largest linear tumor dimension, location of anterior tumor margin, age) and local tumor relapse (location of posterior tumor margin). The follow-up of every relapse-free patient equaled or exceeded the interval to relapse for each matched patient with local relapse. The estimated 5-year survival (Kaplan-Meier) in the relapse-free patients was 87% (standard error = 4%), while that in the local relapse group was 58% (standard error = 6%). This difference is statistically significant (P < 0.0001, log rank test). These results support the hypothesis that local tumor relapse after cobalt 60 plaque radiotherapy is an important post-treatment clinical indicator of the tumor's greater malignant potential and the patient's increased risk of melanoma-specific mortality.

Metrics

8 Record Views
94 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Ophthalmology
Logo image